Ultimately, we found that ECGs presented different profiles across 20 cancer types, with CD47 and TYRO3 more frequently exhibiting copy number increases rather than losses in the majority of tumours, while AXL and HAVCR1 showed a relatively opposite trend (Figure 1E). This evidence concerns the gene HAVCR1 and neoplasm.